Association between non-alcoholic fatty liver disease and epicardial adipose tissue volume with cardiometabolic risk in coronary heart disease

[1] Carr DB(2004)Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087-2094

[2] Utzschneider KM(2016)Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84

[3] Hull RL(2013)Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 330-344

[4] Younossi ZM(2019)Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review J Am Coll Cardiol 73 948-963

[5] Koenig AB(2009)Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease Nutr Metab Cardiovasc Dis 19 211-217

[6] Abdelatif D(2010)Epicardial adipose tissue and coronary artery plaque characteristics Atherosclerosis 210 150-154

[7] Fazel Y(2006)Mechanisms of disease: hepatic steatosis in type 2 diabetes– pathogenesis and clinical relevance Nat Clin Pract Endocrinol Metab 2 335-348

[8] Henry L(2021)The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography Egypt Heart J 73 96-2735

[9] Wymer M(2007)Gamma-glutamyl transferase is associated with incident vascular events independently of alcohol intake Arter Thromb Vasc Boil 27 2729-17

[10] Anstee QM(2014)Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies Atherosclerosis 236 7-1953

[1] Carr DB(2004)Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087-2094

[2] Utzschneider KM(2016)Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84

[3] Hull RL(2013)Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 330-344

[4] Younossi ZM(2019)Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review J Am Coll Cardiol 73 948-963

[5] Koenig AB(2009)Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease Nutr Metab Cardiovasc Dis 19 211-217

[6] Abdelatif D(2010)Epicardial adipose tissue and coronary artery plaque characteristics Atherosclerosis 210 150-154

[7] Fazel Y(2006)Mechanisms of disease: hepatic steatosis in type 2 diabetes– pathogenesis and clinical relevance Nat Clin Pract Endocrinol Metab 2 335-348

[8] Henry L(2021)The associations between coronary artery disease, and non-alcoholic fatty liver disease by computed tomography Egypt Heart J 73 96-2735

[9] Wymer M(2007)Gamma-glutamyl transferase is associated with incident vascular events independently of alcohol intake Arter Thromb Vasc Boil 27 2729-17

[10] Anstee QM(2014)Liver enzymes and risk of cardiovascular disease in the general population: a meta-analysis of prospective cohort studies Atherosclerosis 236 7-1953